InvestSMART

Immuron Limited (ASX: IMC) - Announcements

- Current share price for IMC : $0.037

ASX company news and announcements for Immuron Limited (IMC) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Immuron Limited (IMC) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Immuron Limited (IMC), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Immuron Limited (IMC)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$12 Appendix 3B - Issue of Securities 24 Feb 2016 5:31PM $0.400 $0.037 fallen by 90.75%
$12 Immuron Initiates Pre-Clinical Colitis Development Program 22 Feb 2016 9:57AM $0.380 $0.037 fallen by 90.26%
$12 Immuron Secures upto $1.7M Equity & Convertible Note Funding 17 Feb 2016 1:20PM $0.410 $0.037 fallen by 90.98%
$12 Immuron Receives $1.47M R&D Tax Concession Refund 4 Feb 2016 12:59PM $0.410 $0.037 fallen by 90.98%
$12 US Analyst Reports on Immuron Products and R&D Pipeline 3 Feb 2016 11:56AM $0.415 $0.037 fallen by 91.08%
$12 Analyst Reports on Immuron IMM-529 C. difficile Program 14 Jan 2016 10:42AM $0.435 $0.037 fallen by 91.49%
$12 IMC Achieves Outstanding Results in C-Diff Recurrence Study 12 Jan 2016 11:26AM $0.400 $0.037 fallen by 90.75%
$12 IMC Reports Highly Successful C-Diff Pre-Clinical Results 22 Dec 2015 10:19AM $0.440 $0.037 fallen by 91.59%
$12 Appendix 3B 4 Dec 2015 9:45AM $0.480 $0.037 fallen by 92.29%
$12 Change of Director's Interest Notices x4 - (RA, PA, DP, SA) 4 Dec 2015 9:26AM $0.480 $0.037 fallen by 92.29%
$12 Results of 2015 Immuron Annual General Meeting 25 Nov 2015 5:13PM $0.465 $0.037 fallen by 92.04%
$12 Immuron 2015 Annual General Meeting Presentation 25 Nov 2015 9:37AM $0.460 $0.037 fallen by 91.96%
$12 NASH Clinical Trial Surpasses 25% Patient Recruitment Level 18 Nov 2015 10:09AM $0.440 $0.037 fallen by 91.59%
$12 IMC Signs US Travelan Sales Agreement with Medico-Mart Inc 12 Nov 2015 9:56AM $0.460 $0.037 fallen by 91.96%
$12 Replay of Immuron CEO's Presentation at Microcap Conference 10 Nov 2015 2:21PM $0.450 $0.037 fallen by 91.78%
$12 Appendix 3B - Exercise of Options 9 Nov 2015 5:23PM $0.450 $0.037 fallen by 91.78%
$12 NASH Diagnostic Collaboration Agreement - OWL Metabolomics 9 Nov 2015 10:00AM $0.450 $0.037 fallen by 91.78%
$12 IMC Signs US Travelan Sales P/ship with TravelCare WorldWide 5 Nov 2015 11:25AM $0.435 $0.037 fallen by 91.49%
$12 Notice of Annual General Meeting & Explanatory Memorandum 28 Oct 2015 9:49AM $0.470 $0.037 fallen by 92.13%
$12 Passport Health - Sales Partnership Agreement 26 Oct 2015 2:56PM $0.485 $0.037 fallen by 92.37%
$12 Change of Director's Interest Notice - (PA) 23 Oct 2015 2:15PM $0.495 $0.037 fallen by 92.53%
$12 IMC to Present at RedChip Global Online Microcap Conference 22 Oct 2015 11:01AM $0.510 $0.037 fallen by 92.75%
$12 604 Change of Substantial Shareholder Interest (Grandlodge) 21 Oct 2015 5:15PM $0.510 $0.037 fallen by 92.75%
$12 Appendix 3B - Exercise of Options 19 Oct 2015 7:07PM $0.560 $0.037 fallen by 93.39%
$12 Appendix 3B - Exercise of Options 30 Sep 2015 5:05PM $0.450 $0.037 fallen by 91.78%

651 - 675 of 790 results

Page 27 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.